iPSC-derived Platelets
Thrombocytopenia (Cancer, Liver Disease, Critical Illness)
PreclinicalActive
Key Facts
Indication
Thrombocytopenia (Cancer, Liver Disease, Critical Illness)
Phase
Preclinical
Status
Active
Company
About Xueji Biotechnology
A stem cell biotech using iPSC-derived platelets to create off-the-shelf cell therapies for thrombocytopenia and develop related drugs.
View full company profile